By Admin at 24 Nov 2015, 10:43 AM

On Tuesday, December 1, Gateway for Cancer Research is participating in #GivingTuesday, a global day dedicated to giving. We invite you to join us in this movement that celebrates and promotes generosity around the world.

Some ideas to join the #GivingTuesday movement include:

• Use the hashtag #GivingTuesday to spread the word about the causes most near and dear to your heart.
• Help spread the word about #GivingTuesday by sharing an UNselfie on social media.
• Make a difference on December 1 by donating to Gateway for Cancer Research.

This December Every Dollar Counts – TWICE!

Thanks to a generous donor, beginning on #GivingTuesday and throughout the month of December, your donation to Gateway will be matched – DOUBLING YOUR IMPACT in the fight against cancer!

Gateway believes that if you donate to cancer research, your donation should go to cancer research! 99 cents of every dollar Gateway receives directly funds Phase I and Phase II clinical trials. The research Gateway funds cannot be overstated. Phase I and Phase II clinical trials are underfunded, yet have the greatest patient impact in conquering cancer.

Please consider joining forces with us on #GivingTuesday. Together we can make great strides towards shaping a world in which a cancer diagnosis is no longer feared!

Below, hear Maddy's story, a Gateway-funded clinical trial patient ...

Maddy, College Student and Survivor of Osteosarcoma: “I’m very happy to have been part of Dr. Balis clinical trial because I know it’s helping many kids in the future. It should be a norm, not a last resort. I hope my results from the trial really make a difference, and I hope Gateway can keep going forward and helping others. Thank you for believing in Gateway – I’m living proof that clinical trials do work.”

Post a comment

Make me anonymous

CAPTCHA
Below question is to prevent automated spam submissions.

* Math Question:

2 + 1 =

Solve this math problem and enter the result. E.g. for 1 + 3, enter 4.

You must provide a response to the reCaptcha challenge.